Showing 131-140 of 355 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Early identification strategies to assist with prevention of eating disorders (insulin restriction) in Type 1 diabetes | Penn State College of Medicine | Heather Stuckey | Improving Lives | 01-October-2023 to 31-December-2026 | $488.976,45 |
| Advancing Breakthroughs in Type 1 Diabetes Research with Safe and Immune Cloaked Stem Cells | Pluristyx | Benjamin Fryer | Cures | 15-November-2025 to 14-November-2027 | $704.860,20 |
| Assessing use of primary and secondary CVD prevention therapies in people with T1D and developing strategies to increase uptake | Putnam Associates | Thomas Marder | Improving Lives | 01-August-2026 to 31-July-2027 | $615.000,00 |
| T1D Disease-Modifying Therapy: Immunotherapy Landscape and Prioritization Framework | Quaestio Global Partners, LLC | Magdy Abdel-Malik | Cures | 06-July-2026 to 01-July-2027 | $69.999,00 |
| Evaluation of a novel insulin sensitizer on glycemic control, insulin usage, and cardiovascular biomarkers in people with type 1 diabetes who use closed-loop automated insulin delivery | Rector & Visitors of the University of Virginia | William Horton | Improving Lives | 01-August-2025 to 31-July-2028 | $1.031.908,99 |
| Reducing Glycemic Variability to Improve Cardiovascular Health in Type 1 Diabetes | Rector & Visitors of the University of Virginia | William Horton | Improving Lives | 01-December-2022 to 30-June-2027 | $858.072,00 |
| Alternative Splicing as a Trigger for Initiation and Progression of Islet Autoimmunity | Rector & Visitors of the University of Virginia | Stephen Rich | Cures | 01-February-2026 to 31-January-2029 | $880.914,00 |
| Improving Genetic Risk Scores for Type 1 Diabetes in East Asian Populations | Rector & Visitors of the University of Virginia | Stephen Rich | Cures | 01-June-2026 to 31-May-2029 | $899.995,00 |
| ST2 Tregs in enhancing islet transplantation | Rector & Visitors of the University of Virginia | Rahul Sharma | Cures | 01-July-2025 to 30-June-2028 | $499.997,13 |
| Polyclonal IgM and Its Fcµ Fragment: Preclinical Advances Toward Type 1 Diabetes Therapy | Rector & Visitors of the University of Virginia | Preeti Chhabra | Cures | 01-May-2026 to 30-April-2029 | $982.880,00 |